• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.

作者信息

Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G

机构信息

Mario Negri Institute for Pharmacological Research, Bergamo, Italy.

出版信息

J Am Soc Nephrol. 1996 May;7(5):653-60. doi: 10.1681/ASN.V75653.

DOI:10.1681/ASN.V75653
PMID:8738798
Abstract

Studies in experimental animals and humans have documented that inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitors reduces urinary protein excretion rate and retards the development of renal injury. Here we sought to investigate whether angiotensin II (All) modified the size-selective properties to macromolecules of the glomerular capillary barrier in isolated perfused rat kidney preparation. Compared with basal values, continuous All infusion into the renal artery at the rate of 3 or 8 ng/min, but not at 0.6 ng/min, induced a progressive and significant increase in urinary protein excretion rate. Evaluation of the sieving properties of the glomerular barrier by fractional clearance of polydisperse Ficoll showed that All significantly enhanced the filtration of tracer molecules of radil > or = 34A. All-induced changes in urinary protein excretion rate and in Ficoll fractional clearance were completely prevented by pretreatment with the specific All Type 1 receptor antagonist SR 47436.

摘要

相似文献

1
Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.
J Am Soc Nephrol. 1996 May;7(5):653-60. doi: 10.1681/ASN.V75653.
2
Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.健康受试者外源性输注血管紧张素II后AT1受体阻断的急性肾脏效应
J Cardiovasc Pharmacol. 1998 Feb;31(2):314-21. doi: 10.1097/00005344-199802000-00019.
3
Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.通过血管紧张素转换酶抑制和AT1受体拮抗作用对肾小球血管紧张素II受体的调节。
Regul Pept. 1997 Jan 29;68(2):111-7. doi: 10.1016/s0167-0115(96)02112-x.
4
Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.选择性 A1 受体阻断对肾小球血流动力学的影响:肾素-血管紧张素系统的参与
Am J Physiol. 1994 Nov;267(5 Pt 2):F783-90. doi: 10.1152/ajprenal.1994.267.5.F783.
5
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.瑞舒伐他汀对肾大部切除大鼠肾小球毛细血管大小选择性功能的影响。
Am J Nephrol. 2007;27(6):630-8. doi: 10.1159/000108359. Epub 2007 Sep 11.
6
The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.血管紧张素受体拮抗剂厄贝沙坦可减轻实验性慢性肾衰竭中的肾损伤。
Kidney Int Suppl. 1996 Dec;57:S132-6.
7
[Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats].血管紧张素II受体拮抗剂对生长激素治疗的肾病大鼠的肾脏保护作用
Zhonghua Er Ke Za Zhi. 2003 Nov;41(11):817-21.
8
Rapid, dynamic changes in glomerular permeability to macromolecules during systemic angiotensin II (ANG II) infusion in rats.在大鼠全身血管紧张素 II(ANG II)输注过程中,肾小球对大分子的通透性迅速而动态地变化。
Am J Physiol Renal Physiol. 2012 Sep 15;303(6):F790-9. doi: 10.1152/ajprenal.00153.2012. Epub 2012 Jun 20.
9
Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.血管紧张素II受体阻断对残余肾小球滤过选择性的影响。
Kidney Int. 1993 Feb;43(2):346-53. doi: 10.1038/ki.1993.52.
10
Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease.血管紧张素II受体拮抗剂厄贝沙坦治疗慢性肾病的初步经验。
Eur J Pediatr. 2000 Aug;159(8):590-3. doi: 10.1007/s004310000495.

引用本文的文献

1
Combining Neprilysin Inhibitor With ATR Agonist Is Superior to Combination With ATR Blocker in Providing Reno-Protection in Obese Rats.在为肥胖大鼠提供肾脏保护方面,联合使用中性肽链内切酶抑制剂与ATR激动剂优于联合使用ATR阻滞剂。
Front Pharmacol. 2022 Feb 7;12:778953. doi: 10.3389/fphar.2021.778953. eCollection 2021.
2
Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?足细胞靶向治疗肾病综合征——我们能将内在因素外化吗?
Pediatr Nephrol. 2016 Mar;31(3):393-405. doi: 10.1007/s00467-015-3116-4. Epub 2015 May 5.
3
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway.
血管紧张素 II 通过 Notch1/Snail 通路促进啮齿动物和人类的糖尿病肾脏功能障碍。
Am J Pathol. 2013 Jul;183(1):119-30. doi: 10.1016/j.ajpath.2013.03.025. Epub 2013 May 23.
4
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.miR-324-3p 促进肾纤维化,是 ACE 抑制的作用靶点。
J Am Soc Nephrol. 2012 Sep;23(9):1496-505. doi: 10.1681/ASN.2011121144. Epub 2012 Jul 19.
5
The role of renin angiotensin system inhibition in kidney repair.肾素-血管紧张素系统抑制在肾脏修复中的作用。
Fibrogenesis Tissue Repair. 2010 May 4;3:7. doi: 10.1186/1755-1536-3-7.
6
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.高压氧治疗增强了西拉普利和辛伐他汀方案在实验性肾病综合征模型中的疗效。
Clin Exp Nephrol. 2008 Apr;12(2):110-118. doi: 10.1007/s10157-007-0017-2. Epub 2008 Jan 5.
7
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.他汀类药物治疗可减轻NADPH氧化酶激活及肾小球滤过屏障重塑。
Hypertension. 2008 Feb;51(2):474-80. doi: 10.1161/HYPERTENSIONAHA.107.102467. Epub 2008 Jan 2.
8
Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.肾素-血管紧张素轴阻断可降低家族性局灶节段性肾小球硬化症无症状患者的蛋白尿。
Pediatr Nephrol. 2007 Oct;22(10):1779-84. doi: 10.1007/s00467-007-0505-3. Epub 2007 May 25.
9
Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.血管紧张素II作用下足细胞-足细胞接触的选择通透性功能障碍揭示了肾脏保护干预的分子靶点。
Am J Pathol. 2006 Apr;168(4):1073-85. doi: 10.2353/ajpath.2006.050701.
10
Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition.对血管紧张素转换酶抑制有反应的先天性肾病综合征
Pediatr Nephrol. 2005 Sep;20(9):1340-2. doi: 10.1007/s00467-005-1918-5. Epub 2005 Jun 18.